149 related articles for article (PubMed ID: 19383122)
1. Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database.
Zhou J; Elliott J; Li PC; Lim PL; Kiertiburanakul S; Kumarasamy N; Merati TP; Pujari S; Chen YM; Phanuphak P; Vonthanak S; Sirisanthana T; Sungkanuparph S; Lee CK; Kamarulzaman A; Oka S; Zhang F; Tau G; Ditangco R
BMC Infect Dis; 2009 Apr; 9():46. PubMed ID: 19383122
[TBL] [Abstract][Full Text] [Related]
2. Predicting short-term disease progression among HIV-infected patients in Asia and the Pacific region: preliminary results from the TREAT Asia HIV Observational Database (TAHOD).
Zhou J; Kumarasamy N;
HIV Med; 2005 May; 6(3):216-23. PubMed ID: 15876289
[TBL] [Abstract][Full Text] [Related]
3. Trends in mortality among ART-treated HIV-infected adults in the Asia-Pacific region between 1999 and 2017: results from the TREAT Asia HIV Observational Database (TAHOD) and Australian HIV Observational Database (AHOD) of IeDEA Asia-Pacific.
Jung IY; Rupasinghe D; Woolley I; O'Connor CC; Giles M; Azwa RI; Choi JY;
J Int AIDS Soc; 2019 Jan; 22(1):e25219. PubMed ID: 30615271
[TBL] [Abstract][Full Text] [Related]
4. Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV.
Ku SW; Jiamsakul A; Joshi K; Pasayan MKU; Widhani A; Chaiwarith R; Kiertiburanakul S; Avihingsanon A; Ly PS; Kumarasamy N; Do CD; Merati TP; Nguyen KV; Kamarulzaman A; Zhang F; Lee MP; Choi JY; Tanuma J; Khusuwan S; Sim BLH; Ng OT; Ratanasuwan W; Ross J; Wong WW;
J Int AIDS Soc; 2019 Mar; 22(3):e25264. PubMed ID: 30924281
[TBL] [Abstract][Full Text] [Related]
5. Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy.
Worodria W; Massinga-Loembe M; Mazakpwe D; Luzinda K; Menten J; Van Leth F; Mayanja-Kizza H; Kestens L; Mugerwa RD; Reiss P; Colebunders R;
J Acquir Immune Defic Syndr; 2011 Sep; 58(1):32-7. PubMed ID: 21654499
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis among HIV-infected population: incidence and risk factors in rural Tanzania.
Said K; Verver S; Kalingonji A; Lwilla F; Mkopi A; Charalambous S; Reither K
Afr Health Sci; 2017 Mar; 17(1):208-215. PubMed ID: 29026395
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy.
Liu E; Makubi A; Drain P; Spiegelman D; Sando D; Li N; Chalamilla G; Sudfeld CR; Hertzmark E; Fawzi WW
AIDS; 2015 Jul; 29(11):1391-9. PubMed ID: 26091295
[TBL] [Abstract][Full Text] [Related]
8. Incidence of tuberculosis in HIV-infected patients receiving HAART: interaction between TST and CD4 count.
Martín-Echevarria E; Rodríguez-Zapata M; Torralba M; Fernández JM; Moreno A; Casado JL; Dronda F; Pérez-Elías MJ; Navas E; Moreno S
Int J Tuberc Lung Dis; 2011 Oct; 15(10):1347-52. PubMed ID: 22283893
[TBL] [Abstract][Full Text] [Related]
9. Incidence of tuberculosis and the need of prophylactic treatment in persons living with HIV in Stockholm during the era of anti-retroviral therapy 1996-2013.
Norrby M; Wannheden C; Ekström AM; Berggren I; Lindquist L
Infect Dis (Lond); 2018; 50(11-12):807-816. PubMed ID: 30362392
[TBL] [Abstract][Full Text] [Related]
10. AIDS-defining illness diagnosed within 90 days after starting highly active antiretroviral therapy among patients from the TREAT Asia HIV Observational Database.
Zhou J; Paton NI; Ditangco R
Int J STD AIDS; 2007 Jul; 18(7):446-52. PubMed ID: 17623500
[TBL] [Abstract][Full Text] [Related]
11. High incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National antiretroviral therapy programme between 2011 and 2015.
Mupfumi L; Moyo S; Shin SS; Wang Q; Zetola N; Molebatsi K; Nnawa J; Kgwaadira BT; Bewlay L; Chebani T; Iketleng T; Mogashoa T; Makhema J; Musonda RM; Essex M; Kasvosve I; Gaseitsiwe S
AIDS; 2019 Dec; 33(15):2415-2422. PubMed ID: 31764106
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
Semu M; Fenta TG; Medhin G; Assefa D
BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
[TBL] [Abstract][Full Text] [Related]
13. Association of highly active antiretroviral treatment with incident tuberculosis in people living with HIV/AIDS.
Yen YF; Jen IA; Chuang PH; Chen M; Lan YC; Lee CY; Arthur Chen YM
Ann Epidemiol; 2018 Dec; 28(12):886-892.e3. PubMed ID: 29656849
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.
Williams BG; Dye C
Science; 2003 Sep; 301(5639):1535-7. PubMed ID: 12920302
[TBL] [Abstract][Full Text] [Related]
15. The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.
Braitstein P; Nyandiko W; Vreeman R; Wools-Kaloustian K; Sang E; Musick B; Sidle J; Yiannoutsos C; Ayaya S; Carter EJ
Pediatr Infect Dis J; 2009 Jul; 28(7):626-32. PubMed ID: 19451858
[TBL] [Abstract][Full Text] [Related]
16. Response to HAART in treatment-naive HIV-infected patients with a prior diagnosis of tuberculosis or other opportunistic infections.
Dronda F; Sobrino P; Hernández-Novoa B; Caro-Murillo AM; Montero M; Iribarren JA; Sanz J; Del Mar Alonso M; Labarga P; Bernal E; Moreno S;
Curr HIV Res; 2011 Jun; 9(4):229-36. PubMed ID: 21631429
[TBL] [Abstract][Full Text] [Related]
17. The shift in tuberculosis timing among people living with HIV in the course of antiretroviral therapy scale-up in Malawi.
Tweya H; Feldacker C; Mpunga J; Kanyerere H; Heller T; Ganesh P; Nkosi D; Kalulu M; Sinkala G; Satumba T; Phiri S
J Int AIDS Soc; 2019 Apr; 22(4):e25240. PubMed ID: 31038836
[TBL] [Abstract][Full Text] [Related]
18. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.
Dean GL; Edwards SG; Ives NJ; Matthews G; Fox EF; Navaratne L; Fisher M; Taylor GP; Miller R; Taylor CB; de Ruiter A; Pozniak AL
AIDS; 2002 Jan; 16(1):75-83. PubMed ID: 11741165
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis incidence and mortality in people living with human immunodeficiency virus: a Danish nationwide cohort study.
Martin-Iguacel R; Llibre JM; Pedersen C; Obel N; Stærke NB; Åhsberg J; Ørsted I; Holden I; Kronborg G; Mohey R; Rasmussen LD; Johansen IS
Clin Microbiol Infect; 2022 Apr; 28(4):570-579. PubMed ID: 34438070
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated with Mortality of TB/HIV Co-infected Patients in Ethiopia.
Teklu AM; Nega A; Mamuye AT; Sitotaw Y; Kassa D; Mesfin G; Belayihun B; Medhin G; Yirdaw K
Ethiop J Health Sci; 2017 Feb; 27(Suppl 1):29-38. PubMed ID: 28465651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
